Transactions
20
Insider / CVS HEALTH Corp
KIRBY J SCOTT
Director at CVS HEALTH Corp
- Company
- CVS HEALTH Corp
- First filing on record
- November 21, 2025
- Latest trade on record
- July 25, 2026
- SEC filings
- EDGAR ↗
KIRBY J SCOTT, Director at CVS HEALTH Corp, has disclosed 20 transactions in UAL, CVS since November 21, 2025: 0 purchases (0 open-market buys) and 7 sales, worth about $64.5M at the reported prices. The latest was filed July 28, 2026, 3 days after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
7
Avg. disclosure lag
2.1d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months KIRBY J SCOTT made no purchases and 7 sales worth $55M, plus 13 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
KIRBY J SCOTT has traded 1 stock on record; the largest by dollars is UAL.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 8 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 8 | 577,512 | $9.4M |
| A | Grant or award | 4 | 273,681 | $266K |
| S | Open-market sale | 4 | 328,702 | $37.7M |
| F | Shares withheld for tax | 3 | 156,049 | $17.2M |
| G | Gift | 1 | 20,000 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 17 | 0 | 6 · $42.0M |
| 2025 | 3 | 0 | 1 · $12.9M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| UAL | Sell F | July 25, 2026 | July 28, 2026 | 3d | 28,076 | $118 | $3.3M | Form 4 ↗ | ||
| UAL | Other A | July 25, 2026 | July 28, 2026 | 3d | 71,347 | — | — | Form 4 ↗ | ||
| UAL | Option / conversion M | July 21, 2026 | July 21, 2026 | 0d | 159,321 | — | — | derivative | Form 4 ↗ | |
| UAL | Sell S | July 21, 2026 | July 21, 2026 | 0d | 159,321 | $118 | $18.8M | Form 4 ↗ | ||
| UAL | Option / conversion M | July 21, 2026 | July 21, 2026 | 0d | 159,321 | $59 | $9.4M | Form 4 ↗ | ||
| UAL | Sell S | June 16, 2026 | June 17, 2026 | 1d | 1,078 | $121 | $130K | 10b5-1 plan | Form 4 ↗ | |
| UAL | Sell S | June 15, 2026 | June 17, 2026 | 2d | 48,303 | $121 | $5.9M | 10b5-1 plan | Form 4 ↗ | |
| CVS | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,447 | $97 | $141K | Form 4 ↗ | ||
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 29,314 | — | — | derivative | Form 4 ↗ | |
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 50,560 | — | — | derivative | Form 4 ↗ | |
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 49,561 | — | — | derivative | Form 4 ↗ | |
| UAL | Sell F | February 28, 2026 | March 3, 2026 | 3d | 50,933 | $106 | $5.4M | Form 4 ↗ | ||
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 29,314 | — | — | Form 4 ↗ | ||
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 50,560 | — | — | Form 4 ↗ | ||
| UAL | Option / conversion M | February 28, 2026 | March 3, 2026 | 3d | 49,561 | — | — | Form 4 ↗ | ||
| UAL | Sell F | February 13, 2026 | February 18, 2026 | 5d | 77,040 | $109 | $8.4M | late | Form 4 ↗ | |
| UAL | Other A | February 13, 2026 | February 18, 2026 | 5d | 199,235 | — | — | late | Form 4 ↗ | |
| UAL | Other G | December 3, 2025 | December 3, 2025 | 0d | 20,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| UAL | Sell S | December 3, 2025 | December 3, 2025 | 0d | 120,000 | $108 | $12.9M | 10b5-1 plan | Form 4 ↗ | |
| CVS | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 28, 2026 | Form 4 | 0000100517-26-000155 | 2 | published | EDGAR ↗ |
| July 21, 2026 | Form 4 | 0000100517-26-000142 | 3 | published | EDGAR ↗ |
| June 17, 2026 | Form 4 | 0000100517-26-000120 | 2 | published | EDGAR ↗ |
| May 15, 2026 | Form 4 | 0000064803-26-000072 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0000100517-26-000055 | 7 | published | EDGAR ↗ |
| February 18, 2026 | Form 4 | 0000100517-26-000039 | 2 | published | EDGAR ↗ |
| December 3, 2025 | Form 4 | 0000100517-25-000196 | 2 | published | EDGAR ↗ |
| November 21, 2025 | Form 4 | 0000064803-25-000062 | 1 | published | EDGAR ↗ |
Other insiders at CVS HEALTH Corp
- Mahoney Michael F Chairman, President & CEO 30 rows
- Gebo Kate EVP HR and Labor Relations 28 rows
- Hart Brett J Director 19 rows
- Finucane Anne A. Director 18 rows
- Nocella Andrew P EVP & Chief Commercial Officer 16 rows
- Leskinen Michael D. EVP & Chief Financial Officer 15 rows
- AGUIRRE FERNANDO Director 13 rows
- Enqvist Torbjorn J EVP & Chief Operations Officer 13 rows
- Bokemeier Brigitte Vice President & Controller 12 rows
- Newman Brian Director 10 rows
Everyone on file, with contracts and lobbying under the company's name: CVS HEALTH Corp.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 8 | 20 | November 21, 2025 | July 28, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.